Neuro-Kinesis Corp. (NKC) Founder and CTO, Josh Shachar, a strategic alliance of PFD and portfolio project of the PFD Management Opportunity Fund 3001, LLC, have enjoyed a two-decade long relationship in medical technology development. Josh Shachar will be speaking at the May 28, 2023, Carnap Foundation at the University of Haifa where Neuro-Kinesis Corp. (NKC), in 2022 submitted an Application for Institutional Animal Care and Use Committee Approval (IACUC) for its upcoming animal studies for validation of the Huygens™ – Proteus™ Robotic Arm Surgical Platform. An agreement has been signed with the Technion Institute in Israel to begin the animal study validation of NKC’s surgical platform in Q3 2023. The platform includes the Huygens™ Catheter, the Lorentz™ Active Sheath, and the Proteus™ Robotic Arm which have been in development over the last several years.